Muscle fibrosis is the gradual replacement of functional muscle tissue with stiff, collagen-rich scar tissue, and it occurs whenever the body’s repair process tips from regeneration toward permanent scarring. The condition shows up in a surprisingly wide range of situations: after a bad muscle tear, in genetic diseases like Duchenne muscular dystrophy, as a side effect of radiation therapy, and even as a quiet consequence of aging. Because the excess connective tissue cannot contract the way muscle fibers do, fibrosis progressively erodes strength, flexibility, and quality of life.
How Muscle Fibrosis Develops
Healthy muscle has a remarkable ability to heal. When fibers are damaged, resident stem cells called satellite cells activate, multiply, and fuse together to rebuild the tissue. At the same time, a separate population of cells living between muscle fibers, known as fibro-adipogenic progenitors (FAPs), ramps up to lay down a temporary scaffold of extracellular matrix. That scaffold gives the regenerating fibers something to anchor to. In a normal injury, the scaffold is remodeled and cleared once the new muscle is in place.
Problems begin when the balance between rebuilding muscle and producing connective tissue shifts in favor of the connective tissue. FAPs are the primary source of extracellular matrix in muscle, and when they become dysregulated they deposit collagen faster than it can be cleared, leading to fibrosis.1PubMed Central. Thrown for a loop: fibro-adipogenic progenitors in skeletal muscle fibrosis Research in animal models has shown that when satellite cells are experimentally removed, muscle regeneration fails entirely and connective tissue proliferates dramatically.2PubMed Central. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration The two cell populations depend on each other: satellite cells keep fibroblast activity in check, and fibroblasts support satellite cell function. When either side falters, fibrosis gains ground.
A growth factor called TGF-β is the main chemical signal pushing the process toward scarring. TGF-β drives FAPs to differentiate into collagen-producing myofibroblasts and stimulates them to secrete more matrix components.3PubMed Central. Role of Transforming Growth Factor-β in Skeletal Muscle Fibrosis: A Review Because TGF-β also plays roles in many other cellular processes throughout the body, simply blocking it wholesale is not a viable treatment strategy.4PubMed. Role of TGF-β/SMAD/YAP/TAZ signaling in skeletal muscle fibrosis
Causes and Triggers
Almost anything that damages muscle tissue repeatedly or severely enough can trigger fibrosis. The underlying thread is the same: chronic or overwhelming injury outpaces the muscle’s ability to regenerate, so scar tissue fills the gap. But the specific triggers fall into several distinct categories, and each one comes with its own dynamics.
Muscular Dystrophy
Genetic muscle diseases are among the most studied contexts for muscle fibrosis. In Duchenne muscular dystrophy, a mutation weakens the structural link between muscle fibers and the surrounding connective tissue, making fibers fragile and prone to tearing during normal use.5PubMed Central. Regulation of fibrosis in muscular dystrophy This creates a continuous cycle of damage and attempted repair. An increase in connective tissue within the muscle is detectable in DMD patients even before obvious muscle degeneration appears, suggesting that the fibrotic process starts early and accelerates over time.6PubMed Central. The role of fibrosis in Duchenne muscular dystrophy
Immune cells play a significant role in driving this cycle. Macrophages initially help clean up debris and support regeneration, but when they remain chronically activated they begin secreting large amounts of TGF-β. That persistent TGF-β signal pushes fibroblasts into overdrive, and the collagen they produce progressively replaces functional muscle with stiff scar tissue.7Exploration of Immunology. Macrophages in the pathogenesis of monogenic muscular dystrophies: inflammation, fibrosis, and therapeutic implications In animal models of dystrophy, the cells that produce fibrotic tissue multiply substantially compared to healthy muscle, and they begin expressing markers associated with aggressive scar-forming myofibroblasts.8PubMed. Connective tissue cells expressing fibro/adipogenic progenitor markers increase under chronic damage
Acute Injury and Volumetric Muscle Loss
A single severe muscle injury can also lead to lasting fibrosis. When a large portion of muscle is destroyed at once, whether from a crush injury, a deep laceration, or a surgical complication, the body cannot regenerate enough new fibers to fill the void. Fibrous scar tissue forms instead, and because the scar lacks the contractile properties of muscle, it creates a permanent functional deficit.9PubMed Central. Fibrosis following Acute Skeletal Muscle Injury: Mitigation and Reversal Potential in the Clinic Injuries classified as volumetric muscle loss, where a large block of tissue is lost entirely, heal with extensive fibrosis, minimal muscle regeneration, and poor functional recovery.10Plastic and Aesthetic Research. Scaffold tissue engineering strategies for volumetric muscle loss
Even less catastrophic injuries can lead to fibrosis when combined with nerve damage. Rotator cuff tears are a common clinical example. When the tendon is torn and the nerve supply to the muscle is also compromised, the resulting fibrosis and stiffness are far greater than with the tendon tear alone.11PubMed Central. Skeletal Muscle Fibrosis and Stiffness Increase after Rotator Cuff Tendon Injury and Neuromuscular Compromise in a Rat Model That added stiffness complicates surgical repair by increasing tension at the repair site.
Radiation Therapy
Radiation treatment for cancer can cause a distinct and insidious form of muscle fibrosis known as radiation fibrosis syndrome. Unlike an acute injury, radiation damage tends to unfold slowly. The fibrotic sclerosis may appear weeks, months, or even years after treatment ends and can affect muscle, nerve, and soft tissue within the radiation field.12PubMed Central. Radiation Fibrosis Syndrome: the Evergreen Menace of Radiation Therapy Clinically, radiation fibrosis syndrome can cause muscle weakness, restricted joint movement, and neuropathy, sometimes described as a combined injury to muscles, nerves, and the spinal cord roots all at once.13PubMed. Radiation fibrosis syndrome: neuromuscular and musculoskeletal complications in cancer survivors Because the damage is progressive, cancer survivors need long-term monitoring of the irradiated area.
Aging
Muscle fibrosis is not exclusive to disease or trauma. It is a feature of normal aging. As we get older, satellite cell numbers decline and the immune system shifts in ways that nudge those remaining stem cells toward producing scar tissue rather than new muscle. Transplant experiments in mice have demonstrated this directly: old bone marrow cells placed into young animals reduced satellite cell numbers and pushed satellite cells toward a fibrosis-promoting state.14PubMed Central. Aging of the immune system causes reductions in muscle stem cell populations, promotes their shift to a fibrogenic phenotype, and modulates sarcopenia The age-related accumulation of phosphate in the blood also appears to play a role; in older mice, a low-phosphate diet improved muscular parameters and reduced fibrosis compared to age-matched controls on a normal diet.15PubMed Central. Aging-related hyperphosphatemia impairs myogenic differentiation and enhances fibrosis in skeletal muscle This gradual fibrotic change contributes to the loss of strength and mobility that older adults experience, layered on top of the better-known loss of muscle mass called sarcopenia.
What Fibrotic Muscle Feels Like
Muscle fibrosis does not always announce itself with a dramatic symptom. The hallmark is a creeping stiffness. Because collagen scar tissue is far stiffer than normal muscle, affected areas gradually lose their ability to stretch and contract freely. In research on dystrophic muscle, the increased collagen content and the chemical cross-links holding collagen fibers together have been directly tied to measurable increases in resting tension and stiffness.16PubMed. The role of collagen crosslinking in the increased stiffness of avian dystrophic muscle
For someone living with fibrosis, that stiffness translates into reduced range of motion, difficulty with everyday movements, and a feeling that the muscle is “tight” in a way stretching alone cannot relieve. Weakness develops alongside the stiffness because the scar tissue cannot generate force. When fibrosis follows a rotator cuff injury, for instance, the shoulder may feel both weak and rigid, and the combination makes rehabilitation harder. In muscular dystrophy, progressive fibrosis contributes to the characteristic loss of mobility that worsens with each passing year. And in age-related fibrosis, the symptoms blend with the general decline in muscle performance, making it easy to attribute everything to “just getting older” rather than recognizing fibrosis as a distinct contributor.
Pain is not always a prominent feature, which is one reason fibrosis can progress quietly. When pain does occur, it tends to be related to the stiffness itself: tight, fibrotic tissue pulling on tendons or compressing nerves. In radiation fibrosis syndrome, nerve involvement can add numbness, tingling, or shooting pain to the picture.
How Muscle Fibrosis Is Detected
Historically, confirming fibrosis required a biopsy, taking a small sample of muscle and examining it under a microscope for excessive collagen. That remains the gold standard, but it is invasive and only samples a tiny area. Newer imaging approaches are making it possible to assess fibrosis without cutting into the tissue.
MRI-based techniques can measure changes associated with fibrosis, including shifts in water distribution within the tissue and expansion of the space occupied by extracellular matrix. Ultrasound shear wave elastography, which measures how stiff tissue is by tracking the speed of sound waves through it, has also shown strong correlations with the actual amount of collagen present. A study combining both modalities found that a multi-method index discriminated between fibrotic and normal muscle better than any single measurement alone.17PubMed Central. Non-invasive assessment of skeletal muscle fibrosis in mice using nuclear magnetic resonance imaging and ultrasound shear wave elastography These tools are still being validated for routine clinical use, but they represent a meaningful step toward catching fibrosis earlier and tracking how well treatments are working.
Physical and Mechanical Approaches to Management
There is no simple cure for established muscle fibrosis, but several management strategies can slow its progression and, in some cases, partially reverse it. Exercise and physical therapy are the most accessible interventions. Commonly used approaches like physiotherapy and structured exercise programs have demonstrated the ability to regulate extracellular matrix turnover and promote muscle repair.18PubMed Central. Targeted Therapy for Skeletal Muscle Fibrosis: Regulation of Myostatin, TGF-β, MMP, and TIMP to Maintain Extracellular Matrix Homeostasis
Stretching, in particular, has shown promising results. In an animal model of muscle injury, a sustained stretching protocol significantly reduced fibrosis by roughly 20% from the fourth week onward compared to the non-stretched group, and this reduction was accompanied by increased formation of new muscle fibers.19PubMed. Stretch-Induced Healing of Injured Muscles Is Associated With Myogenesis and Decreased Fibrosis The mechanical stimulus of stretching appears to do two things at once: it signals muscle stem cells to activate and build new tissue, and it helps remodel the existing scar.
Percutaneous needle fasciotomy, a minimally invasive procedure that uses a needle to break up fibrotic bands, has also been studied in combination with stretching. In a rat model of early-stage fibrosis, the combination produced better functional recovery, less tissue damage, and more favorable regulation of the TGF-β signaling pathway than stretching combined with acupuncture alone.20PubMed Central. Mechanistic effects of percutaneous needle fasciotomy combined with stretching on early-stage skeletal muscle fibrosis in rats The idea behind the procedure is straightforward: physically disrupting the dense scar tissue creates space for muscle fibers to regenerate and allows stretching to be more effective.
Drug and Biologic Therapies Under Investigation
The pharmacological side of fibrosis management is still largely experimental, but a few candidates have shown real promise. Pirfenidone, a drug already approved for treating lung fibrosis, significantly improved muscle force output and fatigue resistance in a mouse model of muscle disease related to chronic kidney disease. Another drug in the same study, a matrix metalloprotease inhibitor called batimastat, actually worsened muscle function, highlighting how tricky it is to intervene in the matrix-remodeling process.21PubMed Central. Pirfenidone treatment improves ischemic muscle function in mice with chronic kidney disease That contrast matters: not every strategy that targets collagen or the extracellular matrix will help. Some matrix components are still needed for normal muscle function, so indiscriminate suppression can backfire.
A different approach uses matrix metalloproteinase-1 (MMP-1), an enzyme that specifically breaks down type I collagen, the main structural protein in fibrotic scar tissue. When active MMP-1 was applied to fibrotic muscle in an experimental setting, it reduced scarring and facilitated remodeling of the injured tissue.22PubMed. Matrix metalloproteinase-1 treatment of muscle fibrosis The challenge with enzyme-based therapies is delivering them precisely to the right tissue at the right time. Stem cell and progenitor cell therapies are also being explored, with novel strategies aiming not just to replace damaged tissue but to modulate the scarring response itself.23PubMed Central. Wound healing and fibrosis: current stem cell therapies
The honest picture right now is that no drug has been approved specifically for skeletal muscle fibrosis in humans. Most of the evidence comes from animal studies, and translating those findings into safe, effective human treatments remains a significant hurdle. But the pipeline is more active than it has ever been, driven partly by the urgent need for better treatments in muscular dystrophy.
Nutritional Strategies That May Help
An emerging area of research looks at whether specific nutrients can slow fibrosis progression, especially the age-related variety. A comprehensive review of animal and cell-culture studies identified phytonutrients, vitamins, and certain amino acids as the most promising candidates. Among them, quercetin, a flavonoid found in onions, apples, and berries, stood out for its ability to reduce inflammation, lower collagen deposition, and tamp down oxidative stress across multiple tissue types in rodent and rabbit studies. Sulforaphane, a compound concentrated in broccoli and other cruciferous vegetables, showed similar multi-target effects specifically in mouse skeletal muscle.24PubMed. Nutritional strategies targeting age-related skeletal muscle fibrosis: underlying mechanisms
These findings have not yet been confirmed in human muscle, which the review’s authors explicitly acknowledged. Still, the idea that dietary compounds might be incorporated into a broader intervention strategy alongside exercise and adequate protein intake is appealing precisely because it is low-risk. For older adults already working to maintain muscle health, eating a diet rich in colorful vegetables and adequate protein is reasonable general advice that aligns with the direction of this research, even if the specific anti-fibrotic benefits remain unproven in people.
Sex Differences in Fibrosis Risk
Fibrosis does not affect everyone equally, and biological sex appears to be one of the variables. Across multiple organs, premenopausal women appear to be somewhat protected from developing severe fibrosis, which has led researchers to suspect that sex hormones, estrogen in particular, play a mitigating role.25PubMed Central. Sex related differences in the pathogenesis of organ fibrosis In skeletal muscle specifically, one study found that certain fibrosis-related signaling markers were significantly higher in older women than in older men, suggesting that the protective effect may diminish or reverse after menopause.26PubMed. Age and sex differences in human skeletal muscle fibrosis markers and transforming growth factor-β signaling
The overall body of research on sex differences in muscle fibrosis remains limited, and most of the available evidence comes from studies of other organs like the liver, lungs, and heart. Whether the patterns observed there translate cleanly to skeletal muscle is still an open question. What does seem clear is that hormonal status matters, and postmenopausal women may face a steeper trajectory of fibrotic change than their premenopausal counterparts or men of similar age. For clinicians, this adds another reason to pay attention to musculoskeletal health during and after menopause, beyond the well-known concerns about bone density.
Why Collagen Cross-Linking Makes Fibrosis Hard to Undo
One of the frustrating aspects of muscle fibrosis is that it tends to become more entrenched over time. This is partly because the collagen deposited in fibrotic tissue undergoes chemical cross-linking, a process where bonds form between neighboring collagen molecules, effectively welding the scar into a rigid lattice. Research in dystrophic muscle has shown that the degree of collagen cross-linking directly correlates with how stiff the muscle becomes, and that inhibiting cross-link formation can actually reverse some of that stiffness.16PubMed. The role of collagen crosslinking in the increased stiffness of avian dystrophic muscle
This finding matters for treatment timing. Early-stage fibrosis, where collagen has been deposited but has not yet become heavily cross-linked, is more amenable to remodeling through physical interventions and enzyme-based treatments. Once the cross-links accumulate, the scar becomes progressively more resistant to breakdown. The practical takeaway is that fibrosis is far easier to address when caught early. Waiting until a muscle feels permanently rigid narrows the window for meaningful improvement, which is one reason the development of non-invasive imaging tools for early detection is so important.
Researchers have also observed that the FAPs responsible for laying down this matrix are not static in their behavior. Under conditions of chronic damage, they increasingly take on the characteristics of aggressive myofibroblasts, the same cell type associated with scarring in organs like the liver and lungs.27PubMed Central. Evolving Roles of Muscle-Resident Fibro-Adipogenic Progenitors in Health, Regeneration, Neuromuscular Disorders, and Aging Once that phenotypic switch happens, the fibrotic process becomes self-reinforcing in a way that is difficult to reverse with any single intervention. This is why the most promising management strategies tend to be multimodal, combining physical therapy, pharmacological agents, and potentially nutritional support to hit the problem from several angles at once.